Lifespan- and healthspan-extension therapy: Methane-rich saline may increase life span via up-regulation of its target gene BubR1 and others, 10/May/2018, 7.37 am

Hydrogen-rich saline based therapy for body weight control, energy homeostasis and TIIDM: Hydrogen-rich saline increases REV-ERB and its down stream target genes, inhibits lipid accumulation, improves dyslipidemia and insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM, via up regulation of its target gene, 10/May/2017, 6.00 am
May 10, 2018
Mechanistic insights into how metformin aids in body weight control, energy homeostasis and TIIDM: Metformin, the widely used drug in the treatment of TIIDM, decreases CADM1 and its downstream target genes that inhibit glucose-induced insulin secretion, improves insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM, via up regulation of its target gene, 10/May/2018, 12.43 pm
May 10, 2018
Show all

 What they say: Introduction: 

A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and Department of Pharmacology, School of Medicine, The University of New South Wales, Australia shows that Sirtuin-2 induces the checkpoint kinase BubR1 to increase lifespan. This study was published, in the 1 July  2014 issue of the journal  “EMBO”, by Prof Sinclair, North BJ, and others.


What we say: 

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Lifespan- and healthspan-extension therapy: Methane-rich saline may increase life span via up-regulation of its target gene BubR1 and others


From research findings to Therapeutic Opportunity: 

This study suggests, for the first time, that methane-rich salineby increasing the expression of its target gene, it may: (a) increase the expression of BuBR1; (b) decrease the expression of p70 S6 Kinase; and (c) regulate the expression of a number of longevity-promoting molecules (fig. 1).

[easy_payment currency=”USD”]

Figure 1. Methane-rich saline may extend  mammalian life span via up regulation of BuBR1 and down regulation of p70 S6 Kinase

Figure 2. Methane-rich salilne as a longevity-promoting agent.   It  functions as a longevity-promoter by increasing the expression of BuBR1 and other longevity-promoting genes (fig 1).

 

 

 

 

 

 

 

 

Thereby, it may: (1) increase insulin sensitivity; (2) attenuate cognitive impairment; (3) delay diseases of aging; (4) slow down cardiac aging; (5) promote resistance to bone, immune and motor dysfunction; (6) promote tissue rejuvenation; and (7) prolong median life span. Thus, methyl-rich saline, either alone or in combination with other drugs, may be used to extend the lifespan of an individual (fig.2).


Details on the research findings: 

Idea Proposed/Formulated (with experimental evidence) by:

Dr L Boominathan Ph.D.

Amount: $500#

Undisclosed mechanistic information: How methyl rich saline increases the expression of BubR1 and extends mammalian life-span

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

# Research cooperation


References

Web: http://genomediscovery.org or http://newbioideas.com

CitationBoominathan, L., Lifespan- and healthspan-extension therapy: Methane-rich saline may increase life span via up-regulation of its target gene BubR1 and others, 10/May/2018, 7.37 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at admin@genomediscovery.org

Comments are closed.